OKYO Pharma (OKYO) Receivables (2021 - 2026)
OKYO Pharma (OKYO) posted quarterly Receivables of $520069.0 for Q1 2026, up 110.69% year-over-year from $246842.0 in Q1 2025, and up 110.69% quarter-over-quarter from $246842.0 in Q1 2025.
OKYO Pharma (OKYO) Receivables (2021 - 2026) Analysis & Trends
OKYO Pharma (OKYO) has reported Receivables for 6 consecutive years, with $520069.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables rose 110.69% year-over-year to $520069.0; the TTM figure through Mar 2026 stood at $520069.0 (up 110.69% YoY), while the FY2026 annual figure was $520069.0, up 242.29% from the prior year.
- Receivables climbed to $520069.0 in Q1 2026 per OKYO's latest filing, from $246842.0 in the prior quarter.
- Across five years, Receivables topped out at $933043.0 in Q1 2023 and bottomed at $157523.0 in Q1 2024.
- Historically, Receivables has averaged $537912.6 across 5 years, with a median of $520069.0 in 2026.
- Annual changes were most pronounced in 2022 — Receivables surged 859.28% — and 2024, when it sank 83.12%.
- OKYO Pharma's Receivables stood at $832086.0 in 2022, then increased by 12.13% to $933043.0 in 2023, then tumbled by 83.12% to $157523.0 in 2024, then soared by 56.7% to $246842.0 in 2025, then jumped by 110.69% to $520069.0 in 2026.
- Business Quant data shows OKYO's Receivables at $520069.0 in Q1 2026, $246842.0 in Q1 2025, and $157523.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | OKYO Pharma | 1.47 Bn | 1.47 Bn | - | 380,249.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 520,069.00 |
| Mar 31, 2025 | 246,842.00 |
| Mar 31, 2024 | 157,523.00 |
| Mar 31, 2023 | 933,043.00 |
| Mar 31, 2022 | 832,086.00 |
| Mar 31, 2021 | 86,741.00 |